Cisplatin
DrugArm cisplatin : 75mg/m2, day n*1 and day n*22, And radiotherapy 50 Gy, 2Gy/f
Other names: Arm Cisplatin
NCT Number: NCT02879227
Phase II study of radiochemotherapy for elderly patients with oesophagus cancer.
Looking for future studies?
Notify Me75 year and older
All sexes
Interventional
Phase 2
Phase II study of radiochemotherapy for elderly patients with oesophagus cancer with Radiotherapy = 50 Gy, 2Gy/f ans chemotherapy with 2 arms arm Cisplatin = Cisplatin 75mg/m2 J1J22 or arm Oxaliplatine = oxaliplatine 85mg/m2 every 2 weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Arm cisplatin : 75mg/m2, day n*1 and day n*22, And radiotherapy 50 Gy, 2Gy/f
Other names: Arm Cisplatin
85 mg/m2 every 2 weeks, 6 times And radiotherapy 50 Gy, 2Gy/f
Other names: Arm Oxaliplatin
Time frame: 6 weeks after end of the radiochemotherapy
number of patient with completed treatment
Time frame: 6 weeks after end of the radiochemotherapy
tumoral evaluation at 6 weeks after the treatment
Time frame: 6 weeks after end of the radiochemotherapy
QLQC30
Time frame: 6 weeks after end of the radiochemotherapy
ELD14
Centre Hospitalier Universitaire de Besancon
Other
Phase II of Radiochemotherapy in Elderly Patients With Oesophagus Cancer
Acronym: Chronos
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04902872
Adnexal Diseases, Appendiceal Neoplasms
New Haven, Connecticut, United States
View Trial DetailsNCT03777813
Adenocarcinoma, Carcinoma
Lille, France
View Trial DetailsNCT06582849
Adnexal Diseases, Anal Cancer
St Louis, Missouri, United States
View Trial DetailsNCT03199586
Adnexal Diseases, Advanced or Metastatic Treatment-refractory Solid Tumor Malignancies
Scottsdale, Arizona, United States
View Trial Details